Bitcoin groundbreakers share personal stories of how Bitcoin is changing lives for the better. Host Mauricio Di Bartolomeo, co-founder and CSO of Ledn, speaks with leading Bitcoin voices, entrepreneurs, and human rights advocates to hear their unique journey and practical real-world examples of how Bitcoin has made a positive impact in their lives. Brought to you by Ledn, a leading financial services company built for Bitcoin & digital assets. Ledn offers a suite of lending, saving and tradi ...
…
continue reading
Konten disediakan oleh Proactive Investors. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Proactive Investors atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !
Offline dengan aplikasi Player FM !
Tiziana Life Sciences' Semaglutide Combo Shows Potential in Obesity-Related Liver Inflammation
MP3•Beranda episode
Manage episode 447662698 series 2891889
Konten disediakan oleh Proactive Investors. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Proactive Investors atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to share news the company has announced positive research findings showing the anti-inflammatory potential of the company’s nasal anti-CD3 antibody, foralumab, when used in combination with semaglutide, a GLP-1 agonist marketed as Ozempic and Wegovy. The study, conducted by Dr. Howard Weiner, Selma Boulenouar, PhD, and their team at Brigham and Women’s Hospital, shows the combination significantly improves liver function and reduces inflammation in diet-induced obesity models. The data reveal that nasal anti-CD3 combined with semaglutide not only promotes liver homeostasis but also markedly decreases pro-inflammatory cytokines, suggesting a promising, multifaceted approach to managing obesity and its challenging complications. These findings underline the potential of this therapy as a breakthrough in addressing both obesity and its often treatment-resistant metabolic effects. #proactiveinvestors #tizianalifescienceslts #nasdaq #tlsa #newceo #ivorelrifi #Foralumab #Ozempic #InflammationResearch #MonoclonalAntibody #BiotechNews #IvorElrifi #ClinicalResearch #SPMS #AlzheimersResearch #GLP1 #ProactiveInvestors#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
611 episode
MP3•Beranda episode
Manage episode 447662698 series 2891889
Konten disediakan oleh Proactive Investors. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Proactive Investors atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Tiziana Life Sciences CEO Ivor Elrifi joined Steve Darling from Proactive to share news the company has announced positive research findings showing the anti-inflammatory potential of the company’s nasal anti-CD3 antibody, foralumab, when used in combination with semaglutide, a GLP-1 agonist marketed as Ozempic and Wegovy. The study, conducted by Dr. Howard Weiner, Selma Boulenouar, PhD, and their team at Brigham and Women’s Hospital, shows the combination significantly improves liver function and reduces inflammation in diet-induced obesity models. The data reveal that nasal anti-CD3 combined with semaglutide not only promotes liver homeostasis but also markedly decreases pro-inflammatory cytokines, suggesting a promising, multifaceted approach to managing obesity and its challenging complications. These findings underline the potential of this therapy as a breakthrough in addressing both obesity and its often treatment-resistant metabolic effects. #proactiveinvestors #tizianalifescienceslts #nasdaq #tlsa #newceo #ivorelrifi #Foralumab #Ozempic #InflammationResearch #MonoclonalAntibody #BiotechNews #IvorElrifi #ClinicalResearch #SPMS #AlzheimersResearch #GLP1 #ProactiveInvestors#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
611 episode
Semua episode
×Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.